Claris Lifesciences shares are on watch after PE investor Carlyle exited.

Carlyle sold 11.29 per cent in the company in a block deal on Monday at Rs 277 a share, according to BSE data.

The data showed that among other investors, Emsaf Mauritius and Tata AIA Life Insurance Company bought in block deals.

At 10.35 am, the stock was trading up 1.31 per cent or Rs 3.60 at Rs 278. The stock had lost 11.2 per cent on Monday.

The PE investor exited after nine years and two-fold returns, analysts said.

comment COMMENT NOW